Objective: The study was undertaken to assess hypercoagulability, by using
thromboelastography, in women who use low-dose oral contraceptives (OCs). Study Design …

Objective. To assess the current knowledge concerning progestogen-only contraception
(POC) and risks of venous thromboembolism (VTE). Design and setting. Systematic review …

In the last decade, the contribution of the progestin component of oral contraceptives (OCs)
to the risk of venous thromboembolism (VTE) has come under scrutiny. The publication of 4 …

The use of oral contraceptives is associated with an increased risk of venous thrombosis. It
is now generally accepted that women who use oral contraceptives that contain so-called …

Objective To assess the thrombotic risk associated with oral contraceptive use with a focus
on dose of oestrogen and type of progestogen of oral contraceptives available in the …

Hormonal contraception remains one of the most important contributions to women's health
in the last century. The birth control pill has dramatically changed the medical, social …

Previous reports and reviews indicate differences in effects of second and third generation
combined oral contraceptives (COCs) on haemostasis variables. This review analyses …

Based on epidemiologic data, women who take oral contraceptives seem to have an
increased risk of developing thromboembolic disease. In order to explain this association …

To assess the influence of oral contraceptives (OC) on the risk for venous thromboembolism
(VTE) in young women, a 5-year case-control study including all women 15–44 years old …

Introduction: The pharmacodynamic effects of various combined oral estrogen-progestin
combinations (COC) are examined for their components alone or in the various combined …